迪桑比 (Dysambiol) 是一种来自Dysidea物种的抗炎性Secomeroterpenoid. 海军海绵 海军海绵
Wei-Hua Jiao1, Jia-Xin Li1, Hong-Yan Liu1,2
1Research Center for Marine Drugs, State Key Laboratory of Microbial Metabolism, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Organic letters
|August 23, 2023
概括
研究人员发现了dysambiol,这是一种来自南中国海海绵的新型海洋天然产品. 这种化合物通过调节关键细胞信号通路,表现出显著的抗炎作用.
科学领域:
- 海洋天然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 化学生物学 化学生物学
背景情况:
- 海洋海绵是结构多样化的二次代谢产物的丰富来源.
- 海洋衍生化合物往往具有独特的生物活性.
- 众所周知,Dysidea属是生产生物活性类的.
研究的目的:
- 从Dysidea sp.中分离和描述新的化合物. 海洋海绵. 海洋海绵.
- 为了研究分离的化合物的抗炎潜力.
- 阐明任何观察到的生物活性的作用机制.
主要方法:
- 使用染色学技术将dysambiol分离和净化.
- 通过广泛的光谱分析 (NMR,MS) 阐明结构.
- 使用莫舍尔法和电子圆二元论 (ECD) 计算来确定绝对配置.
- 在脂聚糖 (LPS) 诱导的Raw 264.7巨细胞中抗炎活性的评估.
- 研究包括NF-κB和MAPK在内的信号通路.
主要成果:
- 隔离了dysambiol,一个独特的二聚类体,具有新的支架和乳桥.
- 完整的dysambiol (1) 的结构确定.
- 迪桑比显示出强大的抗炎活性.
- 抗炎作用通过调节NF-κB和MAPK信号通路来调节.
结论:
- 迪桑比醇代表了一类具有独特化学结构的新型二聚胺类.
- 迪桑比醇具有显著的抗炎性质.
- 该化合物的作用机制涉及调节关键的炎症信号级联,突出其治疗潜力.
相关概念视频
Biosynthesis of Lipids
35
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
35
Bacterial Phylum Spirochaetes
40
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
40
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Drugs for Treatment of Diarrhea-Predominant IBS
212
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
212
Spasmolytic Agents: Chemical Classification
916
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
916
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
1.9K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.9K


